# FDA Inspection 1249100 - Maine General Medical Center - August 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/maine-general-medical-center/f4dc7d38-e5a0-4774-aeed-cf6ccf85f34d
Source feed: FDA_Inspections

> FDA Inspection 1249100 for Maine General Medical Center on August 29, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1249100
- Company Name: Maine General Medical Center
- Inspection Date: 2024-08-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1099908 - 2019-07-29](https://www.keypedia.com/records/fda_inspections/maine-general-medical-center/ae6358c9-d891-4083-bd48-4e719c9e73d0)
- [FDA Inspection 557241 - 2009-01-14](https://www.keypedia.com/records/fda_inspections/maine-general-medical-center/7a98efb4-b809-4fc8-8392-7f4d8bb1c71f)

Company: https://www.keypedia.com/companies/maine-general-medical-center/e303e77a-f51d-4bb7-9490-383c12d46bbc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d